Stephen Caltabiano,Eliot Ohlstein,Stewart McCallum
申请号：
US15323685
公开号：
US09907767B2
申请日:
2017.01.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to methods of treating overactive bladder and the symptoms associated therewith, for example, urinary urgency, frequency of mictruitions, nocturia, and urgency urinary incontinence. One treatment method according to the present invention comprises treatment with the beta-3 adrenergic receptor agonist solabegron. Another treatment combination according to the invention comprises solabegron, and a muscarinic receptor antagonist which results in a synergistic effect on the symptoms associated with OAB.
